Guinness Atkinson AI Drug Discovery ETF

98450048YL3A5B41C410

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: 8888
Jurisdiction: US-DE
Entity created: July 10, 2026

Address

Country: United States
Legal address: 251 SOUTH LAKE AVE, SUITE 80091101 PASADENAUnited States (US-CA)
Head office: 850 NEW BURTON ROAD SUITE 20119904 DOVERUnited States (US-DE)

Identifier

LEI: 98450048YL3A5B41C410
Registered: July 22, 2026 at 08:40 AM UTC
Last updated: July 22, 2026 at 08:40 AM UTC
Next renewal: July 22, 2027 at 08:40 AM UTC
Issuer: Ubisecure RapidLEI (529900T8BM49AURSDO55)
Registered with: EDGAR (RA000665)
Identifier: S000109345
Verified against: EDGAR (RA000665)
Verified as: S000109345
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

GUINNESS ATKINSON ASSET MANAGEMENT, INC.
Fund managerUnited States549300YN7M35N8C3T689
GUINNESS ATKINSON FUNDS
Umbrella fundUnited States54930097560RK2KMX577

Why no parent is reported

No direct parent reportedNo ultimate parent reported: The parent is one or more private individuals

Machine access

REST: https://lei.online/v1/entities/98450048YL3A5B41C410This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search